$Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation$

Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation

Accumulating evidence supports the role of radiation therapy in the induction of antitumor immunity. With recent advancements in stereotactic radiation therapy, there is increasing appreciation that, when combined with immune checkpoint blockade, the type of radiation dose and fractionation regimen...

Full description

Bibliographic Details
Main Authors:	Eric C. Ko, MD, PhD, Kimberly Thomas Benjamin, MD, Silvia C. Formenti, MD
Format:	Article
Language:	English
Published:	Elsevier 2018-10-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109418301659

Similar Items

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
by: Hideharu Miura, PhD, et al.
Published: (2023-11-01)

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
by: Susannah G. Ellsworth, MD, et al.
Published: (2022-09-01)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
by: Shigeo Yasuda, MD, PhD, et al.
Published: (2020-03-01)

Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice
by: Maria C. Cuitiño, DVM, PhD, et al.
Published: (2023-07-01)

The virtual cone: A novel technique to generate spherical dose distributions using a multileaf collimator and standardized control-point sequence for small target radiation surgery
by: Richard A. Popple, PhD, et al.
Published: (2018-07-01)

Preparation and In Vitro and In Vivo Antitumor Effects of VEGF Targeting Micelles
by: Jing Chang MD, et al.
Published: (2020-09-01)

Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy
by: Nipun Verma, MD, PhD, et al.
Published: (2024-06-01)

Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies
by: Elizabeth Guimond, MD, FRCPC, et al.
Published: (2022-11-01)

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
by: Adi Diab, et al.
Published: (2020-10-01)

Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung
by: Susan Y. Wu, MD, et al.
Published: (2024-12-01)

Effectiveness of Single-Fraction, Low-Dose, Bilateral Whole Lung Radiation Therapy for Diffuse Alveolar Hemorrhage Secondary to Extramedullary Hematopoiesis: A Case Report and Review of the Literature
by: Beth K. Neilsen, MD, PhD, et al.
Published: (2024-07-01)

Japanese Kampo Medicine Juzentaihoto Enhances Antitumor Immunity in CD1d Mice Lacking NKT Cells
by: Shun Takaku MD, PhD, et al.
Published: (2020-01-01)

Fractionated stereotactic radiation therapy for intact brain metastases
by: Samuel R. Marcrom, MD, et al.
Published: (2017-10-01)

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
by: Robert W. Gao, BS, et al.
Published: (2019-04-01)

Single-fraction 34 Gy Lung Stereotactic Body Radiation Therapy Using Proton Transmission Beams: FLASH-dose Calculations and the Influence of Different Dose-rate Methods and Dose/Dose-rate Thresholds
by: Patricia van Marlen, MSc, et al.
Published: (2022-07-01)

Biological Effective Radiation Dose for Multiple Myeloma Palliation
by: Ruby F. Meredith, MD, PhD, et al.
Published: (2023-07-01)

An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
by: Suneetha Devpura, PhD, et al.
Published: (2021-11-01)

Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma
by: Grace L. Smith, MD, PhD, MPH, et al.
Published: (2017-07-01)

Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade
by: Tara Davidson, MD, et al.
Published: (2022-07-01)

Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum
by: Edvard Abel, MD, et al.
Published: (2022-09-01)

Radiation Dose Sensitivity of Subregions of the Larynx to Patient-Reported Swallowing Outcomes
by: Mark D. Pepin, PhD, et al.
Published: (2024-05-01)

Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
by: Elinore Wieslander, PhD, et al.
Published: (2024-07-01)

Impact of Radiation on Exosomes in Regulating Tumor Immune Microenvironment
by: Silai Yu, MD, et al.
Published: (2024-08-01)

Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy
by: Adam R. Burr, MD, PhD, et al.
Published: (2020-09-01)

Using benchmarked lung radiation dose constraints to predict pneumonitis risk: Developing a nomogram for patients with mediastinal lymphoma
by: Chelsea C. Pinnix, MD, PhD, et al.
Published: (2018-07-01)

Targeting the chromatin structural changes of antitumor immunity
by: Nian-nian Li, et al.
Published: (2024-04-01)

Immune checkpoint: The novel target for antitumor therapy
by: Xianghu Jiang, et al.
Published: (2021-01-01)

Radiation effects on antitumor immune responses: current perspectives and challenges
by: Thomas Walle, et al.
Published: (2018-01-01)

Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose Constraints
by: Wendy B. Harris, PhD, et al.
Published: (2020-09-01)

Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
by: Claire Lhuillier, et al.
Published: (2019-06-01)

Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy
by: Victor J. Gonzalez, MD, et al.
Published: (2017-04-01)

Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters
by: Benjamin T. Cooper, MD, et al.
Published: (2016-10-01)

Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness
by: Julianna K. Bronk, MD, PhD, et al.
Published: (2022-11-01)

Spatially Fractionated Radiation Therapy in Sarcomas: A Large Single-Institution Experience
by: Safia K. Ahmed, MD, et al.
Published: (2024-03-01)

Trends in Radiation Oncology Treatment Fractionation at a Single Academic Center, 2010 to 2020
by: Benjamin A.Y. Cher, MS, et al.
Published: (2022-11-01)

A Prospective Trial of Single-Fraction Radiation to the Tumor Bed with a Novel Breast-Specific Stereotactic Radiation Therapy Device: The GammaPod™
by: Elizabeth M. Nichols, MD, et al.
Published: (2024-04-01)

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
by: Gregory C. Stachelek, MD, PhD, et al.
Published: (2020-01-01)

Novel Postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft Tissue Sarcoma
by: Matthew Mills, MD, et al.
Published: (2024-03-01)

In Vitro α/β Ratio Variations in Cervical Cancer, with Consequent Effects on Equivalent Dose in 2 Gy Fraction in High-Dose-Rate Brachytherapy
by: Cameron Thayer-Freeman, MS, et al.
Published: (2025-03-01)

Systematic Characterization of DNA Methyltransferases Family in Tumor Progression and Antitumor Immunity
by: Fengru Huang MS, et al.
Published: (2024-06-01)